These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24723543)

  • 1. Management of atherosclerotic renovascular disease after Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL).
    Herrmann SM; Saad A; Textor SC
    Nephrol Dial Transplant; 2015 Mar; 30(3):366-75. PubMed ID: 24723543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atherosclerotic renal artery stenosis].
    Sauguet A; Honton B
    Ann Cardiol Angeiol (Paris); 2014 Dec; 63(6):437-41. PubMed ID: 25450992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence and critique of the ASTRAL and CORAL Trials.
    Sarac TP
    Semin Vasc Surg; 2011 Sep; 24(3):162-6. PubMed ID: 22153027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to manage hypertension with atherosclerotic renal artery stenosis?
    Ricco JB; Belmonte R; Illuminati G; Barral X; Schneider F; Chavent B
    J Cardiovasc Surg (Torino); 2017 Apr; 58(2):329-338. PubMed ID: 27998047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues related to renal artery angioplasty and stenting.
    Mousa AY; Bates MC; Broce M; Bozzay J; Morcos R; AbuRahma AF
    Vascular; 2017 Dec; 25(6):618-628. PubMed ID: 28782453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial.
    Cooper CJ; Murphy TP; Matsumoto A; Steffes M; Cohen DJ; Jaff M; Kuntz R; Jamerson K; Reid D; Rosenfield K; Rundback J; D'Agostino R; Henrich W; Dworkin L
    Am Heart J; 2006 Jul; 152(1):59-66. PubMed ID: 16824832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period.
    Mousa AY; Campbell JE; Stone PA; Broce M; Bates MC; AbuRahma AF
    J Vasc Surg; 2012 Feb; 55(2):421-7. PubMed ID: 22112553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent revascularization restores cortical blood flow and reverses tissue hypoxia in atherosclerotic renal artery stenosis but fails to reverse inflammatory pathways or glomerular filtration rate.
    Saad A; Herrmann SM; Crane J; Glockner JF; McKusick MA; Misra S; Eirin A; Ebrahimi B; Lerman LO; Textor SC
    Circ Cardiovasc Interv; 2013 Aug; 6(4):428-35. PubMed ID: 23899868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular versus medical therapy for atherosclerotic renovascular disease.
    Yu MS; Folt DA; Drummond CA; Haller ST; Cooper EL; Brewster P; Evans KL; Cooper CJ
    Curr Atheroscler Rep; 2014 Dec; 16(12):459. PubMed ID: 25301353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER).
    Scarpioni R; Michieletti E; Cristinelli L; Ugolotti U; Scolari F; Venturelli C; Cancarini G; Pecchini P; Malberti F; Maroldi R; Rozzi G; Olivetti L
    J Nephrol; 2005; 18(4):423-8. PubMed ID: 16245247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference.
    Hicks CW; Clark TWI; Cooper CJ; de Bhailís ÁM; De Carlo M; Green D; Małyszko J; Miglinas M; Textor SC; Herzog CA; Johansen KL; Reinecke H; Kalra PA
    Am J Kidney Dis; 2022 Feb; 79(2):289-301. PubMed ID: 34384806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrarenal atherosclerotic disease blunts renal recovery in patients with renovascular hypertension.
    Khangura KK; Eirin A; Kane GC; Misra S; Textor SC; Lerman A; Lerman LO
    J Hypertens; 2014 Jun; 32(6):1300-6. PubMed ID: 24625655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictors of successful renal artery revascularization in atherosclerotic renovascular disease].
    Flisiński M; Manitius J
    Pol Merkur Lekarski; 2005 Aug; 19(110):206-10. PubMed ID: 16245436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the 1990s to CORAL (Cardiovascular Outcomes in Renal Atherosclerotic Lesions) trial results and beyond: does stenting have a role in ischemic nephropathy?
    Böhlke M; Barcellos FC
    Am J Kidney Dis; 2015 Apr; 65(4):611-22. PubMed ID: 25649878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis.
    Saad A; Herrmann SMS; Eirin A; Ferguson CM; Glockner JF; Bjarnason H; McKusick MA; Misra S; Lerman LO; Textor SC
    Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28916603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH).
    Sarafidis PA; Theodorakopoulou M; Ortiz A; Fernandez-Fernández B; Nistor I; Schmieder R; Arici M; Saratzis A; Van der Niepen P; Halimi JM; Kreutz R; Januszewicz A; Persu A; Cozzolino M
    Nephrol Dial Transplant; 2023 Nov; 38(12):2835-2850. PubMed ID: 37202218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerotic Renal Artery Stenosis: Should we Intervene Earlier?
    de Leeuw PW; Postma CT; Spiering W; Kroon AA
    Curr Hypertens Rep; 2018 Apr; 20(4):35. PubMed ID: 29637445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trial.
    Ritchie J; Green D; Chrysochou T; Hegarty J; Handley K; Ives N; Wheatley K; Houston G; Wright J; Neyses L; Chalmers N; Mark P; Patel R; Moss J; Roditi G; Eadington D; Lukaschuk E; Cleland J; Kalra PA
    Nephrol Dial Transplant; 2017 Jun; 32(6):1006-1013. PubMed ID: 27257278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: rationale and study design.
    Bax L; Mali WP; Buskens E; Koomans HA; Beutler JJ; Braam B; Beek FJ; Rabelink TJ; Postma CT; Huysmans FT; Deinum J; Thien T; Schultze Kool LJ; Woittiez AJ; Kouwenberg JJ; van den Meiracker AH; Pattynama PM; van de Ven PJ; Vroegindeweij D; Doorenbos CJ; Aarts JC; Kroon AA; de Leeuw PW; de Haan MW; van Engelshoven JM; Rutten MJ; van Montfrans GA; Reekers JA; Plouin PF; La Batide Alanore A; Azizi M; Raynaud A; Harden PN; Cowling M;
    J Nephrol; 2003; 16(6):807-12. PubMed ID: 14736007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peristenotic Collateral Circulation in Atherosclerotic Renovascular Disease: Association With Kidney Function and Response to Treatment.
    Afarideh M; Zhang X; Ferguson CM; Glockner JF; Lerman A; Textor SC; Lerman LO
    Hypertension; 2020 Aug; 76(2):497-505. PubMed ID: 32507040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.